1339 GMT - Roche Holding has financial room for more deals, CFO Alan Hippe tells investors at a company event in London. The Swiss drugmaker deployed 18.2 billion Swiss francs to deals between 2022 and 2025, and its net debt remained broadly stable, its finance chief says. "The financial flexibility for us is roughly 5 to 7 billion [francs] to do M&A without increasing the debt level," Hippe says. Shares fall 1.3%.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments